| abstract |
Provided is a liquid cannabis composition comprising CBD and/or CBDA at a concentration in the range of from about 26wt% to about 50wt%; at least two mono- terpenes selected from the group consisting of alpha-Pinene, beta-Pinene, Myrcene, Ocimene, Terpinolene, Limonene, Sabinene, Linalool, Carene, Eucalyptol, Terpineol, Geraniol, Borneol, Terpinene, Camphene, Fenchol and combinations thereof; and a carrier, wherein a ratio between a total weight of said mono-terpenes and a total weight of CBD and CBDA is in the range of from about 0.02 to about 0.2. Also provided are methods of use thereof in the treatment of epilepsy and/or an autism spectrum disorder. |